Please login to the form below

Not currently logged in

Biogen completes filing for highly-anticipated Alzheimer’s drug

Alzheimer's trees

FDA has 60 days to decide whether to accept filing for review

Moderna clashes with US scientists over pivotal COVID-19 vaccine trials

Delays allegedly resulting from a lack of cooperation

EU gives AZ’s Lynparza green light for BRCA-mutated pancreatic cancer

AstraZeneca AZPARP inhibitor now available for rare, life-threatening disease

Mesoblast expands compassionate use COVID-19 programme

CoronavirusWill now include children with multisystem inflammatory syndrome

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug

Daiichi AZ allianceAntibody drug conjugate gained approval in US in December

Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK

Coronavirus vaccineAlleged deal could include agreement for 60 million doses

Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus

Novo Nordisk headquartersDrug is first and so far only oral alternative to injectable GLP-1 agonists

New Japanese approvals include first OK for GSK’s anaemia drug Duvroq

GSK - logo on buildingAnd Novartis gets green light for non-small cell lung cancer drug Tabrecta

Novartis pulls EU filing for $3.4bn eye therapy Xiidra

Novartis Basel WebCompany says EMA’s concerns “could not be addressed within the available timeframe”

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

COVID-19 Updates and Daily News

Featured jobs


Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia